monoclonal antibodies

A series of dice with a bag on them illustrating cost cuts
Biotech

Prothena lays off 63% in fallout from phase 3 amyloidosis fail

Prothena is laying off almost two-thirds of its workforce as the Irish biotech navigates the fallout from giving up on its failed amyloidosis drug.
James Waldron Jun 20, 2025 2:23am
Monocled cobra

18 years of self-inflicted snakebites lead to new antivenom

May 2, 2025 2:10pm
Two white lab rats looking out of a cage

FDA plans to end animal testing for new monoclonal antibody INDs

Apr 11, 2025 1:22pm
MA

Ikena, after tough year of layoffs, merges with Inmagene

Dec 23, 2024 10:00am
Photo of an ax atop a pile of three logs

Pyxis whittles pipeline down to one clinical asset

Dec 20, 2024 6:15am
Hand reaching for juice on grocery store shelf

Genmab buys 2nd antibody from Scancell in deal worth up to $630M

Dec 4, 2024 11:55am